City of Hope Enters Licensing Agreement With Chimeric to Develop Its Pioneering Chlorotoxin CAR T Cell Therapy
DUARTE, Calif.--(BUSINESS WIRE)-- #CityofHope--City of Hope licensed intellectual property relating to its chlorotoxin chimeric antigen receptor T cell therapy to Chimeric Therapeutics Limited.
